Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Luigia Carbone

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Vascular Biology (Bristol, England)|December 6, 2021
Interleukin role in the regulation of endothelial cell pathological activationMaria Luigia Carbone, Cristina Maria Failla
Oncotarget|June 21, 2016
Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skinDaniela Lulli, Maria Luigia Carbone, Saveria Pastore
International Journal of Molecular Sciences|October 25, 2017
The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human KeratinocytesDaniela Lulli, Maria Luigia Carbone, Saveria Pastore
International Journal of Molecular Sciences|September 12, 2018
Topical Plant Polyphenols Prevent Type I Interferon Signaling in the Skin and Suppress Contact HypersensitivityMaria Luigia Carbone, Daniela Lulli, Francesca Passarelli, et al.
International Journal of Molecular Sciences|November 17, 2019
Melanoma and Vitiligo: In Good CompanyCristina Maria Failla, Maria Luigia Carbone, Cristina Fortes, et al.
Biomedicines|January 25, 2025
Vascular Endothelial Growth Factor (VEGF) Family and the Immune System: Activators or Inhibitors?Cristina Maria Failla, Maria Luigia Carbone, Carmela Ramondino, et al.
Hypertension (Dallas, Tex. : 1979)|April 15, 2015
Angiotensin II activates the RhoA exchange factor Arhgef1 in humansMaria Luigia Carbone, Jérémy Brégeon, Nabila Devos, et al.
Pharmacological Research|October 18, 2011
Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cellsRosa Calvello, Maria Antonietta Panaro, Maria Luigia Carbone, et al.
International Journal of Molecular Sciences|April 26, 2020
Multiple Sclerosis Treatment and Melanoma DevelopmentMaria Luigia Carbone, Pedro Miguel Lacal, Serena Messinese, et al.
Frontiers in Immunology|September 8, 2023
Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapyMaria Luigia Carbone, Alessia Capone, Marika Guercio, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Vascular Biology (Bristol, England)|December 6, 2021
Interleukin role in the regulation of endothelial cell pathological activationMaria Luigia Carbone, Cristina Maria Failla
Oncotarget|June 21, 2016
Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skinDaniela Lulli, Maria Luigia Carbone, Saveria Pastore
International Journal of Molecular Sciences|October 25, 2017
The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human KeratinocytesDaniela Lulli, Maria Luigia Carbone, Saveria Pastore
International Journal of Molecular Sciences|September 12, 2018
Topical Plant Polyphenols Prevent Type I Interferon Signaling in the Skin and Suppress Contact HypersensitivityMaria Luigia Carbone, Daniela Lulli, Francesca Passarelli, et al.
International Journal of Molecular Sciences|November 17, 2019
Melanoma and Vitiligo: In Good CompanyCristina Maria Failla, Maria Luigia Carbone, Cristina Fortes, et al.
Biomedicines|January 25, 2025
Vascular Endothelial Growth Factor (VEGF) Family and the Immune System: Activators or Inhibitors?Cristina Maria Failla, Maria Luigia Carbone, Carmela Ramondino, et al.
Hypertension (Dallas, Tex. : 1979)|April 15, 2015
Angiotensin II activates the RhoA exchange factor Arhgef1 in humansMaria Luigia Carbone, Jérémy Brégeon, Nabila Devos, et al.
Pharmacological Research|October 18, 2011
Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cellsRosa Calvello, Maria Antonietta Panaro, Maria Luigia Carbone, et al.
International Journal of Molecular Sciences|April 26, 2020
Multiple Sclerosis Treatment and Melanoma DevelopmentMaria Luigia Carbone, Pedro Miguel Lacal, Serena Messinese, et al.
Frontiers in Immunology|September 8, 2023
Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapyMaria Luigia Carbone, Alessia Capone, Marika Guercio, et al.
Pageof 3